FDA gives scientists freedom to tweet in long-awaited social media policy

The FDA has released long-awaited guidance on the use of social media by its staff. The regulator, which has faced criticism in the past over its failure to establish a policy, set out its position in a 12-page document. The document clears FDA staff to set up social media accounts without first obtaining the permission of their managers and empowers them to request corrections to any agency posts that misrepresent their research. Regulatory Focus story | Guidance (PDF)

Suggested Articles

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

Elligo Health Research will test a harmonized real-word data model built by the FDA.

Just about a year after filing its IPO application BGI hits a big wall with a regulatory review.